bromocriptine has been researched along with dimethylaminomicheliolide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cai, X; Cong, Z; Ma, C; Tang, C; Yang, J; Yuan, F; Zhu, J | 1 |
1 other study(ies) available for bromocriptine and dimethylaminomicheliolide
Article | Year |
---|---|
ACT001 reverses resistance of prolactinomas via AMPK-mediated EGR1 and mTOR pathways.
Topics: AMP-Activated Protein Kinases; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cabergoline; Drug Resistance, Neoplasm; Drug Synergism; Early Growth Response Protein 1; Furans; Humans; Pituitary Neoplasms; Prolactinoma; TOR Serine-Threonine Kinases | 2021 |